Endocannabinoid System Clinical Research: 2024 RCT Finds

Clinical Takeaway

A randomized controlled trial tested the Minder mobile app, co-developed with university students, to address mental health and substance use concerns during a high-risk transition period. The study evaluated whether this digital tool could produce measurable improvements in both mental health and substance use outcomes across a general university population. Digital interventions like Minder are being studied because they offer scalable, student-accessible support without requiring in-person clinical resources.

#4 Effectiveness of the Minder Mobile Mental Health and Substance Use Intervention for University Students: Randomized Controlled Trial.

Citation: Vereschagin Melissa et al.. Effectiveness of the Minder Mobile Mental Health and Substance Use Intervention for University Students: Randomized Controlled Trial.. Journal of medical Internet research. 2024. PMID: 38536225.

Study type: Randomized Controlled Trial, Journal Article, Research Support, Non-U.S. Gov’t  |  Topic area: Anxiety & PTSD  |  CED Score: 12

Design: 5 Journal: 0 N: 3 Recency: 1 Pop: 2 Human: 1 Risk: 0

Why This Matters
This RCT provides rigorous evidence on whether a student-centered digital intervention can effectively reduce mental health and substance use symptoms during a critical developmental period when these conditions typically emerge. The findings are clinically significant because they evaluate a scalable, acceptable mobile platform that could address the documented gap in mental health service access for university students while reducing burden on already-strained campus mental health systems. If effective, this intervention offers an evidence-based digital tool that clinicians and student health services can integrate into standard care pathways to extend treatment reach beyond traditional in-person counseling capacity.

Abstract: BACKGROUND: University attendance represents a transition period for students that often coincides with the emergence of mental health and substance use challenges. Digital interventions have been identified as a promising means of supporting students due to their scalability, adaptability, and acceptability. Minder is a mental health and substance use mobile app that was codeveloped with university students. OBJECTIVE: This study aims to examine the effectiveness of the Minder mobile app in improving mental health and substance use outcomes in a general population of university students. METHODS: A 2-arm, parallel-assignment, single-blinded, 30-day randomized controlled trial was used to evaluate Minder using intention-to-treat analysis. In total, 1489 participants were recruited and randomly assigned to the intervention (n=743, 49.9%) or waitlist control (n=746, 50.1%) condition. The Minder app delivers evidence-based content through an automated chatbot and connects participants with services and university social groups. Participants are also assigned a trained peer coach to support them. The primary outcomes were measured through in-app self-assessments and included changes in general anxiety symptomology, depressive symptomology, and alcohol consumption risk measured using the 7-item General Anxiety Disorder scale, 9-item Patient Health Questionnaire, and US Alcohol Use Disorders Identification Test-Consumption Scale, respectively, from baseline to 30-day follow-up. Secondary outcomes included measures related to changes in the frequency of substance use (cannabis, alcohol, opioids, and nonmedical stimulants) and mental well-being. Generalized linear mixed-effects models were used to examine each outcome. RESULTS: In total, 79.3% (589/743) of participants in the intervention group and 83% (619/746) of participants in the control group completed the follow-up survey. The intervention group had significantly greater average reductions in anxiety symptoms measure

Clinical Perspective

🧠 This randomized controlled trial examining a student-developed mental health and substance use app addresses a genuine clinical need, as university transitions often precipitate or unmask psychiatric and addiction vulnerabilities in young adults. Digital interventions like Minder hold genuine promise for scalability and reducing barriers to care, particularly for populations hesitant to seek traditional mental health services. However, the abstract excerpt provided lacks critical detail about primary outcomes, effect sizes, follow-up duration, and potential selection bias inherent in app-based studies where engagement and retention often correlate with baseline health motivation. Additionally, we should note that app-based interventions frequently show diminishing real-world effectiveness compared to controlled trial results, and the absence of information on whether this trial compared Minder to standard care, waitlist control, or attention control affects interpretability of findings. From a clinical standpoint, while digital mental health tools may usefully complement traditional outreach at campus health centers and lower barriers for some students, they should be positioned as adjunctive rather than substitutional, with clear

Full Article  |  PubMed  |  PMC Full Text